Market Closed -
Other stock markets
|
After market 03:58:01 pm | |||
1.295 EUR | -6.83% | 1.298 | +0.23% |
12:46pm | Medigene, BioNTech Extend Cancer Immunotherapy Partnership | MT |
May. 15 | Medigene AG Presents Preclinical Data on Optimal Affinity TCRs Targeting the Neoantigen Mutant KRAS | CI |
- Stock Market
- Equities
- MDG1 Stock
- News Medigene AG
- MarketScreener Strategies